is dulaglutide a glp-1 Peptide sequences and molecular structures of FDA approved RAs Indications for GLP-1/GIP RA Summary

These events stimulate the secretion of insulin, helping to compensate for insulin resistance triggered by new-onset diabetes. The drug also suppresses glucagon release by the pancreas, resulting in glucose-dependent reduction in plasma glucose and postprandial glucose by inhibiting hepatic glucose production and delaying gastric emptying. GLP-1s also act in brain regions associated with appetite and reward, reducing food intake and promoting weight loss

Ulcerative colitis: where we are and where we are not in 2020

Many patients find their tolerance for alcohol decreases significantly on GLP-1 therapy

IGF-1 support More GH means more downstream IGF-1